In the STEP UP trial, people using Wegovy 7.2 mg once weekly lost an average of 20.7% of their body weight after 72 weeks of treatment
doi:10.1016/S0021-9258(18)42531-8 59
Cardiovascular risk reduction : Wegovy is covered by some plans, including Medicare Part D, when prescribed for cardiovascular risk reduction in patients with established heart disease and BMI 27 or higher
Promotional positioning and headline marketing phrases appearing on the brand's website - including, without limitation, "365-Day Feel Good Guarantee," "Stock Up and Save," and "45% off" promotional discount framing - are explicitly identified in this article as brand-stated marketing language and are not represented as independently verified performance guarantees or independently ranked designations by this publication
Dont pick at any scabs that develop after laser hair removal treatments
Skin is dry and sensitive, thus always stay shy of brightening products